AKT1 and head and neck squamous cell carcinoma: Further, by enhancing de novo cholesterol biosynthesis [Figure 2], squalene epoxidase (SQLE) promoted the activation of downstream PI3K/Akt and induced cisplatin resistance in head and neck squamous cell carcinoma (HNSCC)[12] [Table 1].